| NCT04475224 | Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury | Kringle Pharma, Inc. | | - Age 18 - 89 yrs
- Level C4-C8
AIS A- ≤ 78 hours
| | 25 | PHASE3 | Drug | General health | | | 13 July 2020 | 17 July 2020 | 5 | |
| NCT04528550 | Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury | Shanghai Changzheng Hospital | | - Age 18 - 60 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 2 weeks
| | 45 | PHASE2 | Biological/cell based | General health | | | 01 October 2020 | 27 August 2020 | 1 | |
| NCT04550117 | Intraspinal Pressure Monitoring for Acute Traumatic Spinal Cord Injury: A Validation Study | University of Manitoba | | - Age 18 - 70 yrs
- Level C1-S5
AIS A, B, C- ≤ 48 hours
| | 20 | NA | Surgery | General health | | | 23 June 2020 | 16 September 2020 | 1 | |
| NCT01701388 | EKSO Trial: Powered Exoskeleton for Ambulation in Subjects With Spinal Cord Injury (SCI) | Shirley Ryan AbilityLab | | - Age 18 - 65 yrs
- Level C7-S1
AIS A, B, C, D- ≥ 0 hours
| Active | 40 | NA | Rehabilitation | Standing/walking/mobility | | | 01 May 2012 | 05 October 2012 | 1 | |
| NCT01393977 | Difference Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With Spinal Cord Injury in China | General Hospital of Chinese Armed Police Forces | | - Age 20 - 50 yrs
- Level C1-S5
AIS A, B, C, D- ≤ 50 years
| | 60 | PHASE2 | Biological/cell based | Standing/walking/mobility | | | 01 January 2011 | 14 July 2011 | 1 | |
| NCT01231893 | Transplantation of Autologous Olfactory Ensheathing Cells in Complete Human Spinal Cord Injury | Wroclaw Medical University | | - Age 16 - 65 yrs
- Level C5-L5
AIS A- 3 days - 65 years
| | 10 | PHASE1 | Biological/cell based | General health | | | 01 May 2008 | 01 November 2010 | 1 | |
